Evaluating the Use of Artificial Intelligence to Improve Family Conversations for Intensive Care Patients and Their Families

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorDavy van de Sande

About this trial

This study looks at how artificial intelligence (AI), like generative pre-trained transformer (GPT-4), can help doctors in the intensive care unit (ICU) save time and improve communication with families. Right now, doctors spend a lot of time writing notes after family conversations, which takes time away from patient care. The investigators are testing whether AI can create accurate and easy-to-understand summaries of these conversations, making it quicker for doctors to document and clearer for families to understand. ICU doctors and adult family members of patients will take part in this study, with their full consent. The goal is to see if this new technology can make life easier for doctors while helping families better understand medical information.

Eligibility criteria

Qualifiers

Informed-consent is signed by all participating family members during the conversation.

Informed-consent is signed by the ICU healthcare professionals.

The patient of the family must be admitted to the adult ICU.

All participating family members must be 18 years or older.

Disqualifiers

Trained to interpret medical jargon and/or intensive care terminology specifically

Difficulty reading and/or writing in the Dutch language

Trial design

Treatments tested in this trial

  • Not listed

Trial groups

No trial groups listed

Sponsors and collaborators

Davy van de Sande

Lead sponsor

Erasmus Medical Center

Sponsor institution